Annual Drug Patent Expirations for FETROJA
Fetroja is a drug marketed by Shionogi Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has sixty-nine patent family members in thirty-six countries.
The generic ingredient in FETROJA is cefiderocol sulfate tosylate. One supplier is listed for this compound. Additional details are available on the cefiderocol sulfate tosylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com